Results 71 to 80 of about 14,424,551 (309)

Association of Adults With Congenital Heart Disease–Specific Care With Clinical Characteristics and Healthcare Use [PDF]

, 2021
Abigail Khan, Lidija McGrath, Katrina Ramsey, Anushree Agarwal, Craig S. Broberg   +4 more
openalex   +1 more source

Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2. [PDF]

, 2012
B-type natriuretic peptide (BNP) and NT-proBNP are widely used plasma biomarkers for the diagnosis of acute decompensated heart failure and prognosis for future cardiac disease.
Wu, Alan HB
core   +1 more source

ST2 and Multimarker Testing in Acute Decompensated Heart Failure [PDF]

, 2015
Most data on heart failure biomarkers have been derived from patient cohorts with chronic disease. However, risk prediction in patients admitted with acute decompensated heart failure (ADHF) remains a challenge.
Antoni, Md, Bayes, Genis, DI SOMMA, Salvatore, Maisel, Alan S., Md,, Md,, Md,, Mebazaa, Alexandre   +7 more
core   +1 more source

Pulse Oximetry Screening for Detecting Critical Congenital Heart Disease in Neonates [PDF]

, 2022
Deepshikha Jain, Manish Jain, Yashwant Lamture   +2 more
openalex   +1 more source

Chagas' heart disease [PDF]

Arquivos Brasileiros de Cardiologia, 1999
Chagas’ disease is a protozoan infection caused by Trypanosoma cruzi and is mainly acquired by vectorial transmission in endemic areas, when infected excreta of Triatominae bugs are inoculated into the sting site or neighbouring mucous membranes of the victim.
Marin-Neto, José Antonio, Simões, Marcus Vinícius, Sarabanda, Álvaro V. Lima   +2 more
openaire   +5 more sources

Rabbit models of heart disease. [PDF]

, 2008
Human heart disease is a major cause of death and disability. A variety of animal models of cardiac disease have been developed to better understand the etiology, cellular and molecular mechanisms of cardiac dysfunction and novel therapeutic strategies ...
Bers, Donald M, Pogwizd, Steven M
core  

Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis [PDF]

, 2016
Objective: First-degree atrioventricular block is frequently encountered in clinical practice and is generally considered a benign process. However, there is emerging evidence that prolonged PR interval may be associated with adverse outcomes. This study
Barker, Diane, Beynon, Rhys, Buchan, Iain, Kwok, Chun Shing, Loke, Yoon K, Mamas, Mamas A, Morley-Davies, Adrian, Myint, Phyo K, Nolan, James, Patwala, Ashish, Rashid, Muhammad, Satchithananda, Duwarakan   +11 more
core   +1 more source

Artificial intelligence-based, non-invasive assessment of the central aortic pressure in adults after operative or interventional treatment of aortic coarctation

Open Heart
Background Aortic coarctation (CoA) is a congenital anomaly leading to upper-body hypertension and lower-body hypotension. Despite surgical or interventional treatment, arterial hypertension may develop and contribute to morbidity and mortality ...
Renate Oberhoffer, Peter Ewert, Harald Kaemmerer, Nicole Nagdyman, Oliver Dewald, Frank Klawonn, Michael Huntgeburth, Andreas Eicken, Christian Meierhofer, Sebastian Freilinger, Martin Middeke, Pinar Bambul Heck, Annika Freiberger, Frank Harig, Manuel Lösch, Fritz Mellert, Fabian von Scheidt, Elsa Ury, Nicole Wolfrum, Ann-Sophie Kaemmerer-Suleiman, Mathieu N. Suleiman   +20 more
doaj   +1 more source

Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention

Platelets, 2020
In patients with acute coronary syndrome (ACS), treatment using ticagrelor demonstrated significant ischemic benefits over clopidogrel; however, it was associated with increased bleeding complications leading to frequent de-escalation to clopidogrel. The
Chenggang Wang, Wen Zheng, Ayman Shaqdan, Chunmei Wang, Xiuchuan Qin, Xuedong Zhao, Xu Wang, Lin Yuan, Shaoping Nie, Ran Liu   +9 more
doaj   +1 more source

The “Fracking” technique: a novel approach to crack deep calcified plaque in the common femoral artery with hydraulic pressure

CVIR Endovascular, 2021
Background The patency achieved by conventional peripheral interventions for atherosclerotic lesions in the common femoral artery (CFA), called the “no stenting zone”, is not superior to that achieved by surgical endarterectomy due to calcified plaque ...
Takuya Haraguchi, Tsutomu Fujita, Yoshifumi Kashima, Masanaga Tsujimoto, Tsuyoshi Takeuchi, Yutaka Tadano, Daisuke Hachinohe, Umihiko Kaneko, Ken Kobayashi, Daitaro Kanno, Katsuhiko Sato   +10 more
doaj   +1 more source